Clinical Trials Logo
  1. Home
  2. Disruptive Behavior Disorder
  3. NCT02488499

Addressing Behaviour and Treatment Effectiveness Project (A.B.A.T.E. Project) — ABATE  

Disruptive Behavior Disorder Clinical Trial

Official title:
Addressing Behaviour and Treatment Effectiveness Project (A.B.A.T.E. Project)

Clinical Trial Summary

This study investigates the effectiveness of a clinic-adapted version of the Coping Power program compared to individualized child and family treatment for children with disruptive behaviour and their parents.

Clinical Trial Description

This project compares the short- and long-term effectiveness of a clinic-adapted manualized group treatment (i.e., Coping Power; CP) to individualized child and family treatment for children aged 9 - 12 with disruptive behaviour. Children and their parents who meet criteria and agree to participate in the project are randomly assigned to either the CP condition or the Individualized treatment condition. In the CP condition, children and caregivers are asked to participate in two separate but complimentary 15-session groups. Child groups target development of children's emotional and cognitive problem solving skills and caregiver groups facilitate cognitive and behavioural parenting skills. In the Individualized treatment condition children and caregivers are asked to participate in 15 one-hour individual and family treatment sessions tailored by the clinician to address the children and parent's presenting concerns. Measurement of behaviour and emotional functioning is done pre- post- and at 6-months following treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02488499
Study type Interventional
Source Centre for Addiction and Mental Health
Contact
Status Completed
Phase N/A
Start date July 2010
Completion date December 2016
View Details
See also
  Status Clinical Trial Phase
Completed NCT00250354 - A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation Phase 3
Completed NCT03698240 - Mindfulness-based Program for Children With Disruptive Behavior Disorder N/A
Completed NCT01750996 - Strongest Families Finland Canada: Family-based Prevention and Treatment Program of Early Childhood Disruptive Behavior Phase 1/Phase 2
Recruiting NCT06373484 - Matching Assessment and Treatment for Children With Disruptive Behaviour and Their Parents N/A
Completed NCT02783560 - Behavioral Sleep Intervention in Children With Disruptive Behaviors N/A
Recruiting NCT02812537 - Clinical and Social Trajectories of Children and Adolescents With Disruptive Behavior
Recruiting NCT04298437 - Addressing Depression and Positive Parenting Techniques (ADAPT) N/A
Completed NCT02704221 - Enhancing the Outcomes of a Behavioral Parent Training Intervention N/A
Completed NCT00236470 - A Study of the Safety of Risperidone in the Treatment of Children and Adolescents With Conduct and Other Disruptive Behavior Disorders Phase 3
Recruiting NCT04113161 - Navigating Resource-Constrained Systems and Communities to Promote the Behavioral Health of Black Youth N/A
Enrolling by invitation NCT05425381 - Improving Social, Emotional, Behavioral, and Academic Functioning N/A
Completed NCT03796663 - Mindful Parenting and Parent Training Program Study N/A
Completed NCT00266552 - A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental Retardation Phase 3